This gene encodes a nuclear protein that has three zinc fingers at the end of its C-terminal domain, a serine/threonine-rich central region, and an acidic domain lying within the N-terminal region. The zinc fingers of this protein are responsible for the specific DNA binding with the guanine-rich core promoter elements. The central region might be involved in activation or posttranslational regulatory pathways, and the acidic N-terminal domain might play an important role in the process of transcriptional activation. It is capable of activating transcription approximately 4-fold either on homologous or heterologous promoters. The DNA binding and transcriptional activity of this protein, in conjunction with its expression pattern, suggests that this protein may participate in the regulation and/or maintenance of the basal expression of pregnancy-specific glycoprotein genes and possibly other TATA box-less genes. Two transcript variants encoding the same protein have been found for this gene.
↑Onyango P, Koritschoner NP, Patrito LC, Zenke M, Weith A (Feb 1998). "Assignment of the gene encoding the core promoter element binding protein (COPEB) to human chromosome 10p15 by somatic hybrid analysis and fluorescence in situ hybridization". Genomics. 48 (1): 143–4. doi:10.1006/geno.1997.5124. PMID9503030.
↑Botella LM, Sánchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CP, Ramirez JR, Friedman S, Bernabéu C (Dec 2002). "Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury". Blood. 100 (12): 4001–10. doi:10.1182/blood.V100.12.4001. PMID12433697.
El Rouby S, Newcomb EW (Dec 1996). "Identification of Bcd, a novel proto-oncogene expressed in B-cells". Oncogene. 13 (12): 2623–30. PMID9000136.
Koritschoner NP, Bocco JL, Panzetta-Dutari GM, Dumur CI, Flury A, Patrito LC (Apr 1997). "A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene". The Journal of Biological Chemistry. 272 (14): 9573–80. doi:10.1074/jbc.272.14.9573. PMID9083102.
Suzuki T, Yamamoto T, Kurabayashi M, Nagai R, Yazaki Y, Horikoshi M (Aug 1998). "Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter". Journal of Biochemistry. 124 (2): 389–95. doi:10.1093/oxfordjournals.jbchem.a022124. PMID9685731.
Okano J, Opitz OG, Nakagawa H, Jenkins TD, Friedman SL, Rustgi AK (May 2000). "The Krüppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact". FEBS Letters. 473 (1): 95–100. doi:10.1016/S0014-5793(00)01468-X. PMID10802067.
Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA, Friedman SL (Dec 2001). "KLF6, a candidate tumor suppressor gene mutated in prostate cancer". Science. 294 (5551): 2563–6. doi:10.1126/science.1066326. PMID11752579.
Botella LM, Sánchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CP, Ramirez JR, Friedman S, Bernabéu C (Dec 2002). "Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury". Blood. 100 (12): 4001–10. doi:10.1182/blood.V100.12.4001. PMID12433697.
Chen HK, Liu XQ, Lin J, Chen TY, Feng QS, Zeng YX (Oct 2002). "[Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas]". Ai Zheng = Aizheng = Chinese Journal of Cancer. 21 (10): 1047–50. PMID12508640.
Warke VG, Nambiar MP, Krishnan S, Tenbrock K, Geller DA, Koritschoner NP, Atkins JL, Farber DL, Tsokos GC (Apr 2003). "Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6". The Journal of Biological Chemistry. 278 (17): 14812–9. doi:10.1074/jbc.M300787200. PMID12590140.
Jeng YM, Hsu HC (Jul 2003). "KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas". International Journal of Cancer. 105 (5): 625–9. doi:10.1002/ijc.11123. PMID12740910.
Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE (Jun 2003). "Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene". Plastic and Reconstructive Surgery. 111 (7): 2133–9. doi:10.1097/01.PRS.0000060531.98180.32. PMID12794452.
Reeves HL, Narla G, Ogunbiyi O, Haq AI, Katz A, Benzeno S, Hod E, Harpaz N, Goldberg S, Tal-Kremer S, Eng FJ, Arthur MJ, Martignetti JA, Friedman SL (Apr 2004). "Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer". Gastroenterology. 126 (4): 1090–103. doi:10.1053/j.gastro.2004.01.005. PMID15057748.
Kimmelman AC, Qiao RF, Narla G, Banno A, Lau N, Bos PD, Nuñez Rodriguez N, Liang BC, Guha A, Martignetti JA, Friedman SL, Chan AM (Jun 2004). "Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6". Oncogene. 23 (29): 5077–83. doi:10.1038/sj.onc.1207662. PMID15064720.
Rubinstein M, Idelman G, Plymate SR, Narla G, Friedman SL, Werner H (Aug 2004). "Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53". Endocrinology. 145 (8): 3769–77. doi:10.1210/en.2004-0173. PMID15131018.